Lifeboat Foundation

Scientists long believed the brain was immutable, unable to recover functions lost to injury or disease. But in the past few decades, researchers have devised methods to manipulate the brain and central nervous system to help the paralyzed move and enable the blind to see, and they’re moving closer to restoring lost cognitive abilities.

“We are at an inflection point where we are starting to give functions back to people,” said Michael Lim, MD, professor and chair of neurosurgery.

Steelmaking is currently extremely carbon intensive, accounting for about 7% of total global greenhouse gas emissions. As we continue to use ever more steel for new infrastructure around the world, the task of decarbonising the industry is growing ever more urgent. Hydrogen can now perform that task and Volvo has just taken delivery of the first consignment of carbon-free steel. So how is it done, and will it be a gamechanger for the auto industry and wider world?

Video Transcripts available at our website.
http://www.justhaveathink.com.

Continue reading “Carbon Free Steel becomes a reality at Volvo and Mercedes Benz” »

I’m convinced a lot of diseases, MS, parkinsons, alzheimers, most cancers, are the result of bacterial or viral infections.

Building on a growing body of evidence linking viral infections with neurodegenerative disease, a new study published in Nature Communications has demonstrated how certain molecules on the surfaces of viruses can promote the aggregation of toxic proteins associated with diseases such as Alzheimer’s and Parkinson’s.

The idea that microbial infections can trigger neurodegenerative disease is not new. As far back as the 1950s scientists have been postulating ways an acute viral infection can lead to progressive neurological problems years, or even decades, later.

Continue reading “New evidence shows how viral infections could promote Alzheimer’s” »

I am pleased to share our most recent video on the “Dementia Safety Study” funded by Maximum Life Foundation and run by IHS, in which BioViva did the data analysis. This treatment shows promise for the millions of people who have dementia today. Though not a cure, it is a step in the right direction.

Can gene therapy delay or reverse Alzheimer’s and other dementias?

Continue reading “Human Dementia Study: BioViva Analyzes the Data” »

Summary: Researchers have linked Fragile X and SHANK3 deletion syndrome, two disorders associated with autism, to specific microscopic walking patterns.

Source: Rutgers.

Rutgers researchers have linked the genetic disorders Fragile X and SHANK3 deletion syndrome – both linked to autism and health problems – to walking patterns by examining the microscopic movements of those wearing motion-sensored sneakers.

Taking psilocybin can affect one’s emotional state when listening to music, according to new research presented earlier this month at the 34th ECNP Congress in Lisbon.

Psilocybin, the active psychedelic component of magic mushrooms, has previously shown great promise when used in therapy settings for the treatment of depression. Many of these clinical trials often make use of selected music playlists to support the subjective psychedelic experience felt by the trial participant.

Now, scientists believe that this action of combining psilocybin with music may result in enhanced emotional processing on behalf of the participant, implying that music should be treated as a more active component of psilocybin therapy.

Collaboration, transparency & urgency for rare disease research — mike graglia, managing director & co-founder, syngap research fund — SRF.

Mike Graglia is the Managing Director & Co-Founder of the SynGAP Research Fund (SRF — https://www.syngapresearchfund.org/), an organization that he set up in 2018 with his wife Ashley, after their son was diagnosed with a rare neurological disease caused by an insufficiency in SynGAP protein, which causes the life-changing diagnoses of Epilepsy, Autism, sleep disorder and intellectual disability.

Continue reading “Mike Graglia, Managing Dir & Co-Founder, SynGAP Research Fund — Collaboration, Transparency, Urgency” »

Protein intake is known to be vital for maintaining brain function in older individuals. Now, using a mouse model of Alzheimer’s disease, researchers have shown that the intake of a specific set of amino acids can inhibit the death of brain cells, protect the connections between them, and reduce inflammation, preserving brain function. Their research suggests that this amino acid combination called Amino LP7 can hinder the development of dementia, including Alzheimer’s disease.

One explanation for this could be the degree of efficiency of each organism’s response to the damage sustained by its cells during its life, which eventually causes them to age. In relation to this, researchers at the Universitat Oberta de Catalunya (UOC) and the University of Leicester (United Kingdom) have developed a new method to remove old cells from tissues, thus slowing down the aging process.